These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 35386698)
1. Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study. Vandebergh M; Becelaere S; ; Dubois B; Goris A Front Immunol; 2022; 13():834644. PubMed ID: 35386698 [TBL] [Abstract][Full Text] [Related]
2. Obesity and Multiple Sclerosis: A Mendelian Randomization Study. Mokry LE; Ross S; Timpson NJ; Sawcer S; Davey Smith G; Richards JB PLoS Med; 2016 Jun; 13(6):e1002053. PubMed ID: 27351487 [TBL] [Abstract][Full Text] [Related]
3. Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study. Vandebergh M; Dubois B; Goris A Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35393342 [TBL] [Abstract][Full Text] [Related]
4. Effect of age at puberty on risk of multiple sclerosis: A mendelian randomization study. Harroud A; Morris JA; Forgetta V; Mitchell R; Smith GD; Sawcer SJ; Richards JB Neurology; 2019 Apr; 92(16):e1803-e1810. PubMed ID: 30894442 [TBL] [Abstract][Full Text] [Related]
5. Childhood obesity and multiple sclerosis: A Mendelian randomization study. Harroud A; Mitchell RE; Richardson TG; Morris JA; Forgetta V; Davey Smith G; Baranzini SE; Richards JB Mult Scler; 2021 Dec; 27(14):2150-2158. PubMed ID: 33749377 [TBL] [Abstract][Full Text] [Related]
6. Age-specific effects of childhood body mass index on multiple sclerosis risk. Hone L; Jacobs BM; Marshall C; Giovannoni G; Noyce A; Dobson R J Neurol; 2022 Sep; 269(9):5052-5060. PubMed ID: 35532785 [TBL] [Abstract][Full Text] [Related]
7. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study. Lu H; Wu PF; Zhang W; Liao X Front Immunol; 2021; 12():647588. PubMed ID: 33936066 [TBL] [Abstract][Full Text] [Related]
8. Chickenpox and multiple sclerosis: A Mendelian randomization study. Zhu G; Zhou S; Xu Y; Gao R; Zhang M; Zeng Q; Su W; Wang R J Med Virol; 2023 Jan; 95(1):e28315. PubMed ID: 36380510 [TBL] [Abstract][Full Text] [Related]
9. The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis. Harroud A; Manousaki D; Butler-Laporte G; Mitchell RE; Davey Smith G; Richards JB; Baranzini SE Mult Scler; 2021 Nov; 27(13):1994-2000. PubMed ID: 33605807 [TBL] [Abstract][Full Text] [Related]
10. Smoking and multiple sclerosis risk: a Mendelian randomization study. Vandebergh M; Goris A J Neurol; 2020 Oct; 267(10):3083-3091. PubMed ID: 32529581 [TBL] [Abstract][Full Text] [Related]
11. Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study. Tang Y; Liu W; Kong W; Zhang S; Zhu T Front Immunol; 2023; 14():1077088. PubMed ID: 36845101 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization Study. He D; Liu L; Shen D; Zou P; Cui L Front Immunol; 2022; 13():867693. PubMed ID: 35619713 [TBL] [Abstract][Full Text] [Related]
13. Little evidence for an effect of smoking on multiple sclerosis risk: A Mendelian Randomization study. Mitchell RE; Bates K; Wootton RE; Harroud A; Richards JB; Davey Smith G; Munafò MR PLoS Biol; 2020 Nov; 18(11):e3000973. PubMed ID: 33253141 [TBL] [Abstract][Full Text] [Related]
14. Association between inflammation and cognition: Triangulation of evidence using a population-based cohort and Mendelian randomization analyses. Slaney C; Sallis HM; Jones HJ; Dardani C; ; Tilling K; Munafò MR; Davey Smith G; Mahedy L; Khandaker GM Brain Behav Immun; 2023 May; 110():30-42. PubMed ID: 36791891 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study. Mokry LE; Ross S; Ahmad OS; Forgetta V; Smith GD; Goltzman D; Leong A; Greenwood CM; Thanassoulis G; Richards JB PLoS Med; 2015 Aug; 12(8):e1001866. PubMed ID: 26305103 [TBL] [Abstract][Full Text] [Related]
16. Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms: A Genetic Correlation and 2-Sample Mendelian Randomization Study. Kappelmann N; Arloth J; Georgakis MK; Czamara D; Rost N; Ligthart S; Khandaker GM; Binder EB JAMA Psychiatry; 2021 Feb; 78(2):161-170. PubMed ID: 33079133 [TBL] [Abstract][Full Text] [Related]
17. Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis. Harroud A; Marrie RA; Fitzgerald KC; Salter A; Lu Y; Patel M; Kowalec K Mult Scler; 2021 Nov; 27(13):2077-2084. PubMed ID: 33591230 [TBL] [Abstract][Full Text] [Related]
18. Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis. Wang R J Transl Med; 2022 Jan; 20(1):3. PubMed ID: 34980161 [TBL] [Abstract][Full Text] [Related]
19. Telomere length and multiple sclerosis: a Mendelian randomization study. Ma Y; Wang M; Chen X; Ruan W; Yao J; Lian X Int J Neurosci; 2024 Jun; 134(3):229-233. PubMed ID: 35791675 [TBL] [Abstract][Full Text] [Related]
20. Reassessing the causal role of obesity in breast cancer susceptibility: a comprehensive multivariable Mendelian randomization investigating the distribution and timing of exposure. Hao Y; Xiao J; Liang Y; Wu X; Zhang H; Xiao C; Zhang L; Burgess S; Wang N; Zhao X; Kraft P; Li J; Jiang X Int J Epidemiol; 2023 Feb; 52(1):58-70. PubMed ID: 35848946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]